Purification and renaturation of recombinant human interleukin-2.
about
Solubility as a function of protein structure and solvent components.The effects of N-ethyl-N'-methyl imidazolium chloride on the solubility, stability and aggregation of tc-rPA.Effects of temperature on Escherichia coli overproducing beta-lactamase or human epidermal growth factor.The use of sarkosyl in generating soluble protein after bacterial expression.Folding and Purification of Insoluble (Inclusion Body) Proteins from Escherichia coli.Uncoupling of stem cell inhibition from monocyte chemoattraction in MIP-1alpha by mutagenesis of the proteoglycan binding site.Molecular dissection of the interactions of an antitumor interleukin-2-derived mutein on a phage display-based platform.Purification and characterization of recombinant human interleukin 4. Biological activities, receptor binding and the generation of monoclonal antibodies.Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2.Choice of cellular protein expression system.Insufficient (sub-native) helix content in soluble/solid aggregates of recombinant and engineered forms of IL-2 throws light on how aggregated IL-2 is biologically active.Isolation, renaturation, and formation of disulfide bonds of eukaryotic proteins expressed in Escherichia coli as inclusion bodies.Affinity purification of insoluble recombinant fusion proteins containing glutathione-S-transferase.Protein refolding in reversed micelles.Protein refolding in reversed micelles. 1990.Enhancing enzymatic activity of penicillin G acylase by coexpressing pcm gene.Folding and purification of insoluble (inclusion body) proteins from Escherichia coli.Single-chain antibody variable region-targeted interleukin-2 stimulates T cell killing of human colorectal carcinoma cells.
P2860
Q30334367-4B462E78-E796-4A75-A5AD-CD52BBF38597Q35088874-2F675363-E8CE-40F0-A638-81004C4A17A6Q35700146-857505CF-27FC-4213-B621-BDA184704F56Q37397550-2D7BDA91-059A-4CD1-B6C4-4C56F8246A86Q38264756-69721C1D-94C5-45B1-9372-8E27917F2C67Q38350708-990DA0A5-135C-4F87-A871-D1AEC7CDB7CAQ38909407-0F4E646F-269D-42D5-B593-0F93B2BF126CQ42803200-5AAF76D4-3B25-41FD-84A9-08CF90B493D4Q43126371-802B56F6-DD14-4543-A4A0-5DE057B5FD7EQ45966460-3443C58C-FCE3-492C-A13C-1257D4BDE538Q46846878-3C8029DC-1E08-476C-8207-A540EC033949Q47868036-7EA1ADC5-88BE-47CA-8CDB-EC2C918630C1Q47868563-780956F7-D820-49B5-9117-D155EA2464E9Q47869838-70BCEEB8-D7F2-44F3-91E2-41F888AAA8E0Q48587922-21972938-4125-4929-81B7-160A7832E170Q51243785-6E1DB4DE-2DA8-452E-B928-307F18E45F7AQ54423617-2E187C3D-8238-42F4-9BE6-C5DF2679223FQ54629925-F706AC3E-296D-4A9E-B2DA-8735ED7FBED8
P2860
Purification and renaturation of recombinant human interleukin-2.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Purification and renaturation of recombinant human interleukin-2.
@en
type
label
Purification and renaturation of recombinant human interleukin-2.
@en
prefLabel
Purification and renaturation of recombinant human interleukin-2.
@en
P2860
P356
P1433
P1476
Purification and renaturation of recombinant human interleukin-2.
@en
P2093
P2860
P356
10.1042/BJ2450085
P407
P577
1987-07-01T00:00:00Z